category,datetime,headline,id,image,related,source,summary,url
company,1769467804,Moderna (MRNA) Stock Falls Amid Market Uptick: What Investors Need to Know,138266089,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,MRNA,Yahoo,"Moderna (MRNA) closed the most recent trading day at $47.99, moving 1.48% from the previous trading session.",https://finnhub.io/api/news?id=36a8f52e3925692f1a96c69cfbcb6eb73f994c553a36efccbb1e415dbe92b106
company,1769466143,"Stock Market Today, Jan. 20: ImmunityBio Soars Again After FDA Outlines Resubmission Path for ANKTIVA in Bladder Cancer",138265523,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,MRNA,Yahoo,"On Jan. 20, 2026, investors weigh ImmunityBio’s sharp rally on new FDA feedback around its bladder cancer plans.",https://finnhub.io/api/news?id=8f34abecc389df29645e0d3b78a95aea9e4bc141feab1250d573f89c3dbfb25e
company,1769428800,"Moderna to Report Fourth Quarter 2025 Financial Results on Friday, February 13, 2026",138260525,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,MRNA,Yahoo,"CAMBRIDGE, MA / ACCESS Newswire / January 26, 2026 / Moderna, Inc. (NASDAQ:MRNA), today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Friday, February 13, 2026 to report its fourth quarter 2025 financial results, ...",https://finnhub.io/api/news?id=1079d6855f0c2bb4811443fbfa76d0338bb108a8917e227b9ea5ad7715bab27a
company,1769419161,LABD: ETF To Benefit From Downturns In The Biotech Industry,138261543,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1211369368/image_1211369368.jpg?io=getty-c-w1536,MRNA,SeekingAlpha,"Learn how LABD delivers -3x daily biotech exposure, why itâs down 99.98% since inception, and when it fits short-term trades.",https://finnhub.io/api/news?id=29b529b6fef2b71c6a19dec808fd606f05266acf14eddcb458a0266621f13933
company,1769401899,1 Volatile Stock to Own for Decades and 2 We Ignore,138260526,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,MRNA,Yahoo,"Market swings can be tough to stomach, and volatile stocks often experience exaggerated moves in both directions. While many thrive during risk-on environments, many also struggle to maintain investor confidence when the ride gets bumpy.",https://finnhub.io/api/news?id=526aa216685a7daa0c16c67f64473eec4db6b02a5a140cc5ee4c9f1244310054
